PRGO News and Press, Perrigo Company plc From 08/08/23

2023-08-08 13:30:10 ET Perrigo Company plc (PRGO) Q2 2023 Earnings Conference Call Aug 8, 2023 8:30 AM ET Company Participants Brad Joseph - Vice President, Investor Relations Patrick Taylor - President and Chief Executive Officer Eduardo Bezerra - Executive Vice...

2023-08-08 06:37:29 ET Perrigo press release ( NYSE: PRGO ): Q2 Non-GAAP EPS of $0.63 beats by $0.12 . Revenue of $1.2B (+9.1% Y/Y) beats by $20M . Organic net sales grew 0.8%, including -2.7 percentage points from purposeful SKU prioritization actions to ...

Perrigo Reports Second Quarter Fiscal Year 2023 Financial Results From Continuing Operations PR Newswire Achieved Year-Over-Year and Sequential Gross and Operating Margin Expansion Delivered Strong Operating Income and EPS Growth Reaffirming 2023 Outlook ...

2023-08-07 12:46:53 ET Perrigo ( NYSE: PRGO ) is scheduled to announce Q2 earnings results on Monday, August 7th, after market close. The consensus EPS Estimate is $0.51 (+18.6% Y/Y) and the consensus Revenue Estimate is $1.18B (+7.3% Y/Y).Over the last 2 years, PRGO has b...

Perrigo to Release Second Quarter 2023 Financial Results and Present at an Industry Growth Conference PR Newswire DUBLIN , July 25, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that ...

2023-07-25 00:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-07-21 08:50:00 ET On July 13, Perrigo Company (NYSE: PRGO) announced that regulators at the U.S. Food and Drug Administration (FDA) had given the green light for its Opill birth control pill to be sold over the counter (OTC). The OTC-approved formulation will hit the shelves so...

2023-07-15 10:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-07-14 07:35:00 ET Fifty years. That's how long it's been since the U.S. Food and Drug Administration (FDA) first approved Opill, a daily oral contraceptive. The birth control pill is manufactured by Perrigo 's (NYSE: PRGO) France-based HRA Pharma unit. On Thursday, the FDA ...

Perrigo Announces U.S. FDA Approval for Opill® OTC Daily Oral Contraceptive PR Newswire DUBLIN , July 13, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, announced today that the U.S. Food an...